Literature DB >> 2060579

Redistribution of critical major histocompatibility complex and T cell receptor-binding functions of residues in an antigenic sequence after biterminal substitution.

M J Reddehase1, U H Koszinowski.   

Abstract

Residues critical for establishing a trimolecular interaction with a major histocompatibility complex (MHC)-encoded receptor and a T cell antigen receptor (TcR) were determined for an antigenic nonapeptide. The N-terminal residue proved to be involved in binding of the peptide to both receptors and the C-terminal residue was essential for MHC binding. While substitution of either of these critical terminal residues by alanine resulted in an almost complete loss of peptide antigenicity, simultaneous substitution of both created a new functional ligand for the same MHC molecule and the same TcR. Notably, in the biterminally substituted peptide, the core residues took on new roles in the trimolecular interaction in that a residue critical in the authentic nonapeptide for TcR binding became critical for MHC binding and former spacer residues became essential to various degrees for the interaction with either receptor or both. Thus, apparently, the loss of the terminal residues' contribution was at least partially compensated by a redistribution of the roles among the remaining residues. These results reflect a cooperative contribution of all residues of an antigenic peptide to its binding to both receptors and thus challenge a static definition of agretope and epitope as MHC and TcR binding sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060579     DOI: 10.1002/eji.1830210717

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

Review 1.  Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.

Authors:  Stefan Ebert; Jürgen Podlech; Dorothea Gillert-Marien; Kerstin M Gergely; Julia K Büttner; Annette Fink; Kirsten Freitag; Doris Thomas; Matthias J Reddehase; Rafaela Holtappels
Journal:  Med Microbiol Immunol       Date:  2012-09-13       Impact factor: 3.402

2.  The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.

Authors:  R Holtappels; D Thomas; J Podlech; G Geginat; H P Steffens; M J Reddehase
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Immune control in the absence of immunodominant epitopes: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.

Authors:  Stefan Ebert; Niels A W Lemmermann; Doris Thomas; Angélique Renzaho; Matthias J Reddehase; Rafaela Holtappels
Journal:  Med Microbiol Immunol       Date:  2012-09-14       Impact factor: 3.402

4.  CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.

Authors:  Christian O Simon; Rafaela Holtappels; Hanna-Mari Tervo; Verena Böhm; Torsten Däubner; Silke A Oehrlein-Karpi; Birgit Kühnapfel; Angélique Renzaho; Dennis Strand; Jürgen Podlech; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

5.  Identification of an atypical CD8 T cell epitope encoded by murine cytomegalovirus ORF-M54 gaining dominance after deletion of the immunodominant antiviral CD8 T cell specificities.

Authors:  Rafaela Holtappels; Niels A W Lemmermann; Doris Thomas; Angélique Renzaho; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2015-03-25       Impact factor: 3.402

6.  Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.

Authors:  Verena Böhm; Jürgen Podlech; Doris Thomas; Petra Deegen; Marcus-Folker Pahl-Seibert; Niels A W Lemmermann; Natascha K A Grzimek; Silke A Oehrlein-Karpi; Matthias J Reddehase; Rafaela Holtappels
Journal:  Med Microbiol Immunol       Date:  2008-03-14       Impact factor: 3.402

7.  Specificity of the H-2 L(d)-restricted cytotoxic T-lymphocyte response to the mouse hepatitis virus nucleocapsid protein.

Authors:  C C Bergmann; S A Stohlman
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

8.  Transactivation of cellular genes involved in nucleotide metabolism by the regulatory IE1 protein of murine cytomegalovirus is not critical for viral replicative fitness in quiescent cells and host tissues.

Authors:  Vanessa Wilhelmi; Christian O Simon; Jürgen Podlech; Verena Böhm; Torsten Däubner; Simone Emde; Dennis Strand; Angélique Renzaho; Niels A W Lemmermann; Christof K Seckert; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

9.  Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.

Authors:  Rafaela Holtappels; Christian O Simon; Michael W Munks; Doris Thomas; Petra Deegen; Birgit Kühnapfel; Torsten Däubner; Simone F Emde; Jürgen Podlech; Natascha K A Grzimek; Silke A Oehrlein-Karpi; Ann B Hill; Matthias J Reddehase
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

Review 10.  Reverse genetics modification of cytomegalovirus antigenicity and immunogenicity by CD8 T-cell epitope deletion and insertion.

Authors:  Niels A W Lemmermann; Kai A Kropp; Christof K Seckert; Natascha K A Grzimek; Matthias J Reddehase
Journal:  J Biomed Biotechnol       Date:  2010-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.